YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
5.46
0.00 (0.00%)
At close: Apr 27, 2026, 4:00 PM EDT
5.34
-0.12 (-2.20%)
After-hours: Apr 27, 2026, 7:42 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $383.95 million as of April 27, 2026. Its market cap has increased by 729.85% in one year.
Market Cap
383.95M
Enterprise Value
380.84M
1-Year Change
729.85%
Ranking
Category
Stock Price
$5.46
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $383.95M, an increase of 158.80%. That is a compound annual growth rate of 19.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 383.95M | -55.21% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 401.34M |
| Niagen Bioscience | 398.03M |
| Lineage Cell Therapeutics | 386.09M |
| Enanta Pharmaceuticals | 385.38M |
| Avalo Therapeutics | 385.22M |
| X4 Pharmaceuticals | 382.77M |
| Puma Biotechnology | 382.08M |
| Rocket Pharmaceuticals | 380.84M |